Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Actinium Pharmaceuticals Inc fell by 32.62m. Cash Flow from Financing totalled 14.87m or 18,358.02% of revenues. In addition the company used 47.34m for operations while cash used for investing totalled 153.00k.
Cash flow per share | -1.49 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.43 |
---|---|
Tangible book value per share | 1.43 |
More ▼
Balance sheet in USDView more
Current ratio | 8.95 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0006 |
---|---|
Total debt/total capital | 0.0006 |
More ▼